Patents by Inventor Alain Wellig

Alain Wellig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110178314
    Abstract: The present invention relates to a process for the preparation of a compound of formula wherein R1 is selected from C1-6-alkyl, C3-6-cycloalkyl and aralkyl, and wherein R2 at each occurrence independently is halogen or C1-6-alkyl, and m is an integer from 0 to 4, Q is selected from halogen, —NO2 and —NR3R4, wherein R3 and R4 are independently selected from hydrogen, C1-6-alkyl, C3-6-cycloalkyl, aryl, aralkyl, mesyl and tosyl, or wherein R3 and R4 together form a C4-6-alkylene group, Y at each occurrence is hydrogen or a hydroxy protection group W that can be hydrolytically cleaved under acidic conditions, and n is an integer from 1 to 3, and n is an integer from 1 to 3, with the proviso that n and m together are not greater than 5.
    Type: Application
    Filed: October 10, 2008
    Publication date: July 21, 2011
    Inventors: Alain Wellig, Jean-Paul Roduit, Danmei Dai, Rongmin Chen
  • Patent number: 7608420
    Abstract: Staurosporine of the formula (I) is recovered from a fermentation broth in a process comprising an ultrafiltration and a diafiltration step.
    Type: Grant
    Filed: April 19, 2004
    Date of Patent: October 27, 2009
    Assignee: Lonza AG
    Inventors: Kurt Eyer, Georges Kalbermatten, Jean-Peal Roduit, Alain Wellig
  • Publication number: 20060194294
    Abstract: Staurosporine of the formula (I) is recovered from a fermentation broth in a process comprising an ultrafiltration and a diafiltration step.
    Type: Application
    Filed: April 19, 2004
    Publication date: August 31, 2006
    Inventors: Kurt Eyer, Georges Kalbermatten, Jean-Peal Roduit, Alain Wellig
  • Publication number: 20030149285
    Abstract: The invention relates to a method for producing 1,1′ binaphthalenylidene-4,4′-diones of general formula (I), wherein R1 represents C1-6 alkyl, C1-6 alkoxy, phenyl, substituted phenyl, benzyl or benzyloxy; R2, R3, R4, and R5 independently of one another represent hydrogen, C1-6 alkyl, C1-6 alkoxy, phenyl, substituted phenyl, benzyl or benzyloxy. Production takes place by oxidative coupling of the corresponding naphthols in the presence of a peroxide and a precious metal catalyst.
    Type: Application
    Filed: November 18, 2002
    Publication date: August 7, 2003
    Inventors: Michael Hauck, Josef Heveling, Alain Wellig
  • Patent number: 6075145
    Abstract: Catalyst compositions based on amorphous partially dehydrated zirconium hydroxide which are doped with from 0.01 to 20 atom percent of copper and/or from 0.01 to 20 atom percent of nickel, in each case based on zirconium, and have a specific surface area by the BET method of at least 50 m.sup.2 /g. The catalyst compositions are suitable, in particular, as the catalyst in hydrogen transfer reactions, such as, the Meerwein-Ponndorf-Verley reduction or the Oppenauer oxidation. The preparation of 3-hydroxyquinuclidine of the formula: ##STR1## involves reaction of quinuclidin-3-one with a secondary alcohol in the presence of the amorphous partially dehydrated zirconium hydroxide.
    Type: Grant
    Filed: March 6, 1998
    Date of Patent: June 13, 2000
    Assignee: Lonza AG
    Inventors: Josef Heveling, David Laffan, Alain Wellig
  • Patent number: 6040457
    Abstract: A process for the catalytic conversion of hydroxymethylimidazoles to formylimidazoles. The catalysis takes place in the presence of a peroxide. Formylimidazoles are important intermediates for pharmaceutical active ingredients.
    Type: Grant
    Filed: November 16, 1998
    Date of Patent: March 21, 2000
    Assignee: Lonza AG
    Inventors: Josef Heveling, Alain Wellig
  • Patent number: 5994540
    Abstract: Substituted pyridines of the general formula: ##STR1## wherein R.sup.1 is hydroxyl or chlorine, and a) X is hydrogen or chlorine, R.sup.2 and R.sup.3 together are .dbd.O, R.sup.4 is a group of the formula --OR.sup.5 and R.sup.5 is hydrogen, C.sub.1 -C.sub.4 -alkyl or benzyl orb) X is hydrogen and R.sup.2, R.sup.3 and R.sup.4 together are .dbd.N--NH--, orc) X and R.sup.2 each is hydrogen and R.sup.3 and R.sup.4 together are --O--, ord) X and R.sup.2 each is hydrogen, R.sup.3 is hydroxyl and R.sup.4 is amino or hydroxy.The compounds are obtained by subjecting nicotine to microbiological oxidation to give 5-succinoyl-2-pyridone, followed by chemical reactions. The compounds are suitable as intermediates for the preparation of pharmaceutically active compounds.
    Type: Grant
    Filed: April 30, 1998
    Date of Patent: November 30, 1999
    Assignee: Lonza, Ltd.
    Inventors: Andreas Kiener, Jean-Paul Roduit, Alain Wellig
  • Patent number: 5917051
    Abstract: A process for the catalytic conversion of halogenated hydroxymethylimidazoles to halogenated formylimidazoles. The catalysis takes place in the presence of a peroxide. Halogenated formylimidazoles are important intermediates for pharmaceutical active ingredients.
    Type: Grant
    Filed: October 23, 1998
    Date of Patent: June 29, 1999
    Assignee: Lonza, AG
    Inventors: Josef Heveling, Alain Wellig
  • Patent number: 5856483
    Abstract: A process for preparing 4,6-bis(difluoromethoxy)pyrimidine derivatives of the general formula: ##STR1## wherein R is a C.sub.1-4 -alkyl or optionally substituted phenyl or benzyl, proceeding from the corresponding 4,6-dihydroxypyrimidine dialkali-metal salt. In the process, the educt is reacted under pressure with chlorodifluoromethane in a solvent selected from the group consisting of the ketones, in the presence of a base and a phase-transfer catalyst and in the presence of 40 to 100 mol per mol of water of the 4,6-dihydroxypyrimidine dialkali-metal salt to form the final product.
    Type: Grant
    Filed: July 15, 1997
    Date of Patent: January 5, 1999
    Assignee: Lonza AG
    Inventors: Andreas Naepfli, Jean-Paul Roduit, Alain Wellig
  • Patent number: 5760236
    Abstract: Substituted pyridines of the general formula: ##STR1## wherein R.sup.1 is hydroxyl or chlorine, and a) X is hydrogen or chlorine, R.sup.2 and R.sup.3 together are .dbd.O, R.sup.4 is a group of the formula --OR.sup.5 and R.sup.5 is hydrogen, C.sub.1 -C.sub.4 -alkyl or benzyl, orb) X is hydrogen and R.sup.2, R.sup.3 and R.sup.4 together are .dbd.N--NH--, orc) X and R.sup.2 each is hydrogen and R.sup.3 and R.sup.4 together are --O--, ord) X and R.sup.2 each is hydrogen, R.sup.3 is hydroxyl and R.sup.4 is amino or hydroxyl.The compounds are obtained by subjecting nicotine to microbiological oxidation to give 5-succinoyl-2-pyridone, followed by chemical reactions. The compounds are suitable as intermediates for the preparation of pharmaceutically active compounds.
    Type: Grant
    Filed: November 21, 1995
    Date of Patent: June 2, 1998
    Assignee: Lonza, Ltd.
    Inventors: Andreas Kiener, Jean-Paul Roduit, Alain Wellig
  • Patent number: 5614636
    Abstract: A process for the preparation of carboxamides of nitrogen-containing aromatic heterocyclic compounds from the corresponding N-heterocyclic compounds by reaction thereof with formamide in the presence of peroxodisulfuric acid or a peroxodisulfate.
    Type: Grant
    Filed: May 27, 1994
    Date of Patent: March 25, 1997
    Assignee: Lonza Ltd.
    Inventors: Jean-Paul Roduit, Alain Wellig, Karin Amacker, Martin Eyer
  • Patent number: 5498715
    Abstract: A process for preparing imidazopyridine derivatives of the general formula: ##STR1## wherein R.sub.1 is hydrogen or an alkyl group, and R.sub.2, R.sub.3 and R.sub.4 are identical or different and are hydrogen, an alkyl group, a cycloalkyl group, an aryl group, an aralkyl group or a halogen atom. In this process, a 2-amino-3-nitropyridine is hydrogenated in the presence of a hydrogenation catalyst and the hydrogenation product is condensed with a carboxylic acid simultaneously present in the reaction mixture to give the end product. The imidazopyridine derivatives are intermediates for the preparation of angiotensin II antagonists.
    Type: Grant
    Filed: November 29, 1994
    Date of Patent: March 12, 1996
    Assignee: Lonza Ltd.
    Inventors: David L. Kuo, Martin Eyer, Jean-Paul Roduit, Alain Wellig
  • Patent number: 5446162
    Abstract: A process for the production of 7-acylindoles of the general formula: ##STR1## starting from indoline of the formula: ##STR2## Indoline is cyanized in a first stage to 7-cyanoindoline of the formula: ##STR3## The latter is catalytically dehydrogenated in a second stage to 7-cyanindole of the formula: ##STR4## The latter is then acylated in a third stage with an organometallic compound of the formula:R--Q Vinto the end product according to formula I.
    Type: Grant
    Filed: July 26, 1994
    Date of Patent: August 29, 1995
    Assignee: Lonaz Ltd.
    Inventors: Jean-Paul Roduit, Alain Wellig
  • Patent number: 5380857
    Abstract: A process for the production of 7-acylindoles of the general formula: ##STR1## starting from indoline of the formula: ##STR2## Indoline is cyanized in a first stage to 7-cyanoindoline of the formula: ##STR3## The latter is catalytically dehydrogenated in a second stage to 7-cyanindole of the formula: ##STR4## The latter is then acylated in a third stage with an organometallic compound of the formula:R--Q Vinto the end product according to formula I.
    Type: Grant
    Filed: June 30, 1993
    Date of Patent: January 10, 1995
    Assignee: Lonza Ltd.
    Inventors: Jean-Paul Roduit, Alain Wellig
  • Patent number: 5250689
    Abstract: A process for the production or 2-(methylthio)-disodium barbiturate. Thiourea, malonic acid dimethyl ester and sodium methanolate are reacted to disodium thiobarbiturate. The disodium thiobarbiturate then is reacted with methyl bromide, optionally in the presence of a base, to the end product.
    Type: Grant
    Filed: August 27, 1992
    Date of Patent: October 5, 1993
    Assignee: Lonza, Ltd.
    Inventors: Jean-Paul Roduit, Marcel Etzensperger, Alain Wellig